ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.896,50
-0,14%
S&P 500
5.064,20
0,91%
Dow Jones
38.225,66
0,85%
Euro vs US Dollar
1,07363
0,06%
Bitcoin
59.516,28
0,67%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. IDEXX Laboratories Inc (IDXX)

  7. IDEXX Laboratories Inc (IDXX) News

IDXX IDEXX Laboratories Inc

475,82
7,78 (1,66%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
IDEXX Laboratories Inc IDXX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
7,78 1,66% 475,82 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
465,60 465,60 477,67 475,82 468,04
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.5.202412:30BWIDEXX Laboratories Announces First Quarter Results
04.4.202422:30BWIDEXX Laboratories to Release 2024 First Quarter Financial..
07.3.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202423:56EDGAR2Form 144 - Report of proposed sale of securities
05.3.202423:36EDGAR2Form 144 - Report of proposed sale of securities
04.3.202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202420:00BWIDEXX Laboratories to Present at Two Upcoming Institutional..
16.2.202423:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202423:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202423:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202423:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202423:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202413:00PRNCAIDEXX Launches Vello™, an Innovative Pet Owner Engagement..
12.2.202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.2.202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.2.202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.2.202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.2.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.2.202423:26EDGAR2Form 144 - Report of proposed sale of securities
08.2.202401:01EDGAR2Form 144 - Report of proposed sale of securities
08.2.202400:17EDGAR2Form 144 - Report of proposed sale of securities
05.2.202412:30EDGAR2Form 8-K - Current report
05.2.202412:30BWIDEXX Announces Fourth Quarter and Full Year Results
01.2.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.1.202421:30BWIDEXX Laboratories to Release 2023 Fourth Quarter and Full..
12.1.202413:05PRNUSIDEXX Expands Fecal Dx® Antigen Testing Platform with..
12.1.202413:00PRNCAIDEXX Announces Revolutionary Slide-Free Cellular Analyzer,..
05.1.202423:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
05.1.202423:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
05.1.202423:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
08.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.12.202323:01EDGAR2Form 144 - Report of proposed sale of securities
07.12.202322:15BWIDEXX Laboratories Schedules Two Institutional Investor..
07.12.202322:05EDGAR2Form 8-K - Current report
06.12.202323:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.12.202323:02EDGAR2Form 144 - Report of proposed sale of securities
01.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.11.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.11.202300:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
IDXX
IDEXX Laboratories
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten